NovoCure (NVCR) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17% |
| Dec 31, 2025 | 4.27% |
| Sep 30, 2025 | 5.29% |
| Jun 30, 2025 | 2.46% |
| Mar 31, 2025 | -3.89% |
| Dec 31, 2024 | 3.98% |
| Sep 30, 2024 | 3.15% |
| Jun 30, 2024 | 8.56% |
| Mar 31, 2024 | 3.53% |
| Dec 31, 2023 | 5.08% |
| Sep 30, 2023 | 1.01% |
| Jun 30, 2023 | 3.17% |
| Mar 31, 2023 | -4.86% |
| Dec 31, 2022 | -1.96% |
| Sep 30, 2022 | -7.01% |
| Jun 30, 2022 | 2.41% |
| Mar 31, 2022 | 3.25% |
| Dec 31, 2021 | -0.29% |
| Sep 30, 2021 | 0.07% |
| Jun 30, 2021 | -0.87% |
| Mar 31, 2021 | -6.43% |
| Dec 31, 2020 | 8.51% |
| Sep 30, 2020 | 14.44% |
| Jun 30, 2020 | 13.84% |
| Mar 31, 2020 | 2.61% |
| Dec 31, 2019 | 7.79% |
| Sep 30, 2019 | 6.17% |
| Jun 30, 2019 | 18.28% |
| Mar 31, 2019 | 5.22% |
| Dec 31, 2018 | 7.59% |
| Sep 30, 2018 | 5.27% |
| Jun 30, 2018 | 18.01% |
| Mar 31, 2018 | -2.86% |
| Dec 31, 2017 | 7.09% |
| Sep 30, 2017 | 30.57% |
| Jun 30, 2017 | 10.02% |
| Mar 31, 2017 | 15.34% |
| Dec 31, 2016 | 39.53% |
| Sep 30, 2016 | 20.96% |
| Jun 30, 2016 | 37.28% |
| Mar 31, 2016 | 5.41% |
| Dec 31, 2015 | 38.31% |
| Sep 30, 2015 | 36.83% |
| Jun 30, 2015 | 25.63% |
| Mar 31, 2015 | 37.02% |
| Dec 31, 2014 | -13.10% |